SofWave Medical Statistics

Total Valuation

SofWave Medical has a market cap or net worth of ILS 713.46 million. The enterprise value is 642.90 million.

Market Cap	713.46M
Enterprise Value	642.90M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SofWave Medical has 35.32 million shares outstanding. The number of shares has increased by 1.09% in one year.

Current Share Class	35.32M
Shares Outstanding	35.32M
Shares Change (YoY)	+1.09%
Shares Change (QoQ)	+1.36%
Owned by Insiders (%)	35.26%
Owned by Institutions (%)	16.24%
Float	16.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.03
PB Ratio	7.89
P/TBV Ratio	7.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-36.93
EV / Sales	2.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-64.62

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.06.

Current Ratio	2.25
Quick Ratio	1.88
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.54
Interest Coverage	-14.91

Financial Efficiency

Return on equity (ROE) is -18.62% and return on invested capital (ROIC) is -8.46%.

Return on Equity (ROE)	-18.62%
Return on Assets (ROA)	-5.36%
Return on Invested Capital (ROIC)	-8.46%
Return on Capital Employed (ROCE)	-14.17%
Revenue Per Employee	1.87M
Profits Per Employee	-138,154
Employee Count	126
Asset Turnover	1.51
Inventory Turnover	2.69

Taxes

In the past 12 months, SofWave Medical has paid 1.49 million in taxes.

Income Tax	1.49M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.36% in the last 52 weeks. The beta is 0.70, so SofWave Medical's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+15.36%
50-Day Moving Average	1,905.88
200-Day Moving Average	1,751.53
Relative Strength Index (RSI)	51.45
Average Volume (20 Days)	37,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SofWave Medical had revenue of ILS 235.09 million and -17.41 million in losses. Loss per share was -0.50.

Revenue	235.09M
Gross Profit	178.74M
Operating Income	-13.33M
Pretax Income	-15.92M
Net Income	-17.41M
EBITDA	-8.32M
EBIT	-13.33M
Loss Per Share	-0.50

Full Income Statement

Balance Sheet

The company has 75.96 million in cash and 5.40 million in debt, giving a net cash position of 70.56 million or 2.00 per share.

Cash & Cash Equivalents	75.96M
Total Debt	5.40M
Net Cash	70.56M
Net Cash Per Share	2.00
Equity (Book Value)	90.45M
Book Value Per Share	2.59
Working Capital	78.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.10 million and capital expenditures -845,235, giving a free cash flow of -9.95 million.

Operating Cash Flow	-9.10M
Capital Expenditures	-845,235
Free Cash Flow	-9.95M
FCF Per Share	-0.28

Full Cash Flow Statement

Margins

Gross margin is 76.03%, with operating and profit margins of -5.67% and -7.40%.

Gross Margin	76.03%
Operating Margin	-5.67%
Pretax Margin	-6.77%
Profit Margin	-7.40%
EBITDA Margin	-3.54%
EBIT Margin	-5.67%
FCF Margin	n/a

Dividends & Yields

SofWave Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.09%
Shareholder Yield	n/a
Earnings Yield	-2.44%
FCF Yield	-1.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SofWave Medical has an Altman Z-Score of 5.32 and a Piotroski F-Score of 3.

Altman Z-Score	5.32
Piotroski F-Score	3